Fosun Pharma (02196.HK) plans to spend RMB 250 million to RMB 500 million to repurchase the company's A-shares.
Zhitong Finance APP News, Fosun Pharma (02196.HK) announced that on November 22, 2026, pursuant to the 2026 A-share repurchase authorization, the 45th meeting of the 10th Board of Directors of the Company deliberated and approved the "Proposal on the A-share Repurchase Plan by Way of Centralized Bidding" (hereinafter referred to as the "A-share Repurchase Plan" or "this Repurchase Plan").
Latest
17 m ago

